Non-ischemic Cardiomyopathy in the Elderly: A Shocking Conundrum

Overview

Journal Indian Pacing Electrophysiol J

Date 2019 Jan 8

PMID 30615931

Authors

Deepak Padmanabhan

Samuel J Asirvatham

Affiliations

Soon will be listed here.

References

Barra S, Providencia R, Paiva L, Heck P, Agarwal S . Implantable cardioverter-defibrillators in the elderly: rationale and specific age-related considerations. Europace. 2014; 17(2):174-86. DOI: 10.1093/europace/euu296. View

Nichol G, Stiell I, Hebert P, Wells G, Vandemheen K, Laupacis A . What is the quality of life for survivors of cardiac arrest? A prospective study. Acad Emerg Med. 1999; 6(2):95-102. DOI: 10.1111/j.1553-2712.1999.tb01044.x. View

MOSS A, Hall W, Cannom D, Daubert J, Higgins S, Klein H . Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med. 1996; 335(26):1933-40. DOI: 10.1056/NEJM199612263352601. View

Duray G, Richter S, Manegold J, Israel C, Gronefeld G, Hohnloser S . Efficacy and safety of ICD therapy in a population of elderly patients treated with optimal background medication. J Interv Card Electrophysiol. 2006; 14(3):169-73. DOI: 10.1007/s10840-006-5200-y. View

Reynolds M, Cohen D, Kugelmass A, Brown P, Becker E, Culler S . The frequency and incremental cost of major complications among medicare beneficiaries receiving implantable cardioverter-defibrillators. J Am Coll Cardiol. 2006; 47(12):2493-7. PMC: 1800827. DOI: 10.1016/j.jacc.2006.02.049. View

Costea A, Rardon D, Padanilam B, Fogel R, Prystowsky E . Complications associated with generator replacement in response to device advisories. J Cardiovasc Electrophysiol. 2007; 19(3):266-9. DOI: 10.1111/j.1540-8167.2007.01047.x. View

Reinier K, Narayanan K, Uy-Evanado A, Teodorescu C, Chugh H, Mack W . Electrocardiographic Markers and the Left Ventricular Ejection Fraction have Cumulative Effects on Risk of Sudden Cardiac Death. JACC Clin Electrophysiol. 2016; 1(6):542-550. PMC: 4776651. DOI: 10.1016/j.jacep.2015.07.010. View

Bilchick K, Stukenborg G, Kamath S, Cheng A . Prediction of mortality in clinical practice for medicare patients undergoing defibrillator implantation for primary prevention of sudden cardiac death. J Am Coll Cardiol. 2012; 60(17):1647-55. PMC: 3677038. DOI: 10.1016/j.jacc.2012.07.028. View

Bardy G, Lee K, Mark D, Poole J, Packer D, Boineau R . Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005; 352(3):225-37. DOI: 10.1056/NEJMoa043399. View

10.

Kuck K, Cappato R, Siebels J, Ruppel R . Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest : the Cardiac Arrest Study Hamburg (CASH). Circulation. 2000; 102(7):748-54. DOI: 10.1161/01.cir.102.7.748. View

11.

Healey J, Hallstrom A, Kuck K, Nair G, Schron E, Roberts R . Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias. Eur Heart J. 2007; 28(14):1746-9. DOI: 10.1093/eurheartj/ehl438. View

12.

Yung D, Birnie D, Dorian P, Healey J, Simpson C, Crystal E . Survival after implantable cardioverter-defibrillator implantation in the elderly. Circulation. 2013; 127(24):2383-92. DOI: 10.1161/CIRCULATIONAHA.113.001442. View

13.

Pellegrini C, Lee K, Olgin J, Turakhia M, Tseng Z, Lee R . Impact of advanced age on survival in patients with implantable cardioverter defibrillators. Europace. 2008; 10(11):1296-301. PMC: 2721725. DOI: 10.1093/europace/eun253. View

14.

van Rees J, Borleffs C, Thijssen J, de Bie M, van Erven L, Cannegieter S . Prophylactic implantable cardioverter-defibrillator treatment in the elderly: therapy, adverse events, and survival gain. Europace. 2011; 14(1):66-73. DOI: 10.1093/europace/eur255. View

15.

Tsai V, Goldstein M, Hsia H, Wang Y, Curtis J, Heidenreich P . Influence of age on perioperative complications among patients undergoing implantable cardioverter-defibrillators for primary prevention in the United States. Circ Cardiovasc Qual Outcomes. 2011; 4(5):549-56. DOI: 10.1161/CIRCOUTCOMES.110.959205. View

16.

Krahn A, Connolly S, Roberts R, Gent M . Diminishing proportional risk of sudden death with advancing age: implications for prevention of sudden death. Am Heart J. 2004; 147(5):837-40. DOI: 10.1016/j.ahj.2003.12.017. View

17.

Hamilton G, Carroll D . The effects of age on quality of life in implantable cardioverter defibrillator recipients. J Clin Nurs. 2004; 13(2):194-200. DOI: 10.1046/j.1365-2702.2003.00846.x. View

18.

Wang Y, Sharbaugh M, Althouse A, Mulukutla S, Saba S . Cardiac resynchronization therapy pacemakers versus defibrillators in older non-ischemic cardiomyopathy patients. Indian Pacing Electrophysiol J. 2018; 19(1):4-6. PMC: 6354212. DOI: 10.1016/j.ipej.2018.08.002. View

19.

Moss A, Zareba W, Hall W, Klein H, Wilber D, Cannom D . Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002; 346(12):877-83. DOI: 10.1056/NEJMoa013474. View

20.

Kini V, Khaled Soufi M, Deo R, Epstein A, Bala R, Riley M . Appropriateness of primary prevention implantable cardioverter-defibrillators at the time of generator replacement: are indications still met?. J Am Coll Cardiol. 2014; 63(22):2388-94. PMC: 6007855. DOI: 10.1016/j.jacc.2014.03.025. View